—
C+
C+ The full Closelooknet — membership. Open the C+ overview

TELIX Pharmaceuticals Ltd (TLX.AU) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 35 out of 100 (momentum 44 · quality 30 · valuation 18), as of 2026-11-03.
  • Signal: Mixed moving-average stack — Trades -15.8% vs the 50-day and -6.9% vs the 200-day average, 28.2% below the 52-week high and +58.4% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: TELIX Pharmaceuticals Ltd trades 15.8% below its 50-day and 6.9% below its 200-day moving average. (as of 2026-11-02)

Telix Pharmaceuticals develops radiopharmaceuticals, medicines that pair radioactive isotopes with molecules aimed at cancer cells, used for both imaging and treatment. It runs three business lines, precision medicine, therapeutics and manufacturing solutions, and already sells two prostate-cancer imaging agents, Illuccix and Gozellix.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TLX.AU overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Mixed moving-average stack

Trades -15.8% vs the 50-day and -6.9% vs the 200-day average, 28.2% below the 52-week high and +58.4% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the TLX.AU chart & overview · quality & forensics · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on TLX.AU?

Mixed moving-average stack — Trades -15.8% vs the 50-day and -6.9% vs the 200-day average, 28.2% below the 52-week high and +58.4% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is TLX.AU above its 50-day and 200-day moving averages?

As of 2026-11-02, TELIX Pharmaceuticals Ltd trades -15.8% below its 50-day and -6.9% below its 200-day average, with the 20-day -10.5% away.

How far is TLX.AU from its 52-week high?

28.2% below the 52-week high and 58.4% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.